As of Oct 29, 2024, the DGX stock has a PE ratio of 20.74. The calculation is based on the latest EPS of $7.52 and the stock price of $155.96 per share. An increase of 11% has been observed in the PE ratio compared to its average of 18.7 of the last four quarters.
The mean historical PE ratio of Quest Diagnostics over the last ten years is 16.29. The current 20.74 P/E ratio is 27% higher than the historical average. Looking back at the last ten years, DGX's PE ratio peaked in the Jun 2017 quarter at 21.88, with a price of $111.16 and an EPS of $5.08. The Jun 2021 quarter marked the lowest point at 7.74, with a price of $131.97 and an EPS of $17.06.
Maximum annual increase: 82.59% in 2014
Maximum annual decrease: -33.17% in 2020
Year | PE ratio | Change |
---|---|---|
2023 | 18.17 | -5.9% |
2022 | 19.31 | 76.83% |
2021 | 10.92 | -2.67% |
2020 | 11.22 | -33.17% |
2019 | 16.79 | 8.67% |
2018 | 15.45 | -11.66% |
2017 | 17.49 | -12.86% |
2016 | 20.07 | 38.8% |
2015 | 14.46 | -17.42% |
2014 | 17.51 | 82.59% |
DGX's current PE ratio is higher than the 3, 5 and 10-year averages.
DGX's PE ratio stands lower than its peer stocks LH and QGEN, but it is higher than ENZ's.
Stock name | PE ratio | Market cap |
---|---|---|
ENZ Enzo Biochem Inc | 1.27 | $59.95M |
DGX Quest Diagnostics Inc | 20.68 | $17.36B |
LH Laboratory Corp Of America Holdings | 43.27 | $19.22B |
QGEN Qiagen NV | 151.07 | $9.47B |
NEO Neogenomics Inc | N/A | $1.74B |
DGX's price to earnings ratio is 20.74 as of Oct 29, 2024.
Over the last 3 years, the average price to earnings ratio for DGX stock is 16.24.
Over the last 5 years, the average price to earnings ratio for DGX stock is 14.84.
Over the last ten years, the Jun 2017 quarter recorded the highest quarterly PE ratio at 21.88.
DGX's current price to earnings ratio is 27% above its 10-year historical average.
The P/E ratio is obtained by dividing the latest price of a stock by its trailing twelve months EPS. As of today (Oct 29, 2024), Quest Diagnostics's share price is $155.96. The company's earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $7.52. Therefore, Quest Diagnostics's PE ratio for today is 20.74. PE RATIO(20.74) = STOCK PRICE($155.96) / TTM EPS($7.52)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.